creatine has been researched along with Neurodevelopmental Disorders in 6 studies
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD." | 7.96 | Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020) |
| " We illustrate these limitations of norm-referenced scores, and relative advantages of ability scores, using data from studies of autism spectrum disorder and creatine transporter deficiency." | 3.96 | Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders. ( Akshoomoff, N; Anselm, I; Barshop, BA; Bennett, A; Berry, L; Berry-Kravis, E; Bianconi, S; Bruchey, A; Cecil, KM; Davis, RJ; Farmer, CA; Ficicioglu, C; Goin-Kochel, RP; Guthrie, W; Kaat, AJ; Koeberl, D; Leonczyk, C; Love-Nichols, J; Mamak, E; Mercimek-Andrews, S; Miller, JS; Porter, FD; Spiridigliozzi, GA; Sullivan, N; Sutton, VR; Thomas, RP; Thurm, A; Udhnani, MD; Wainer, A; Waisbren, SE, 2020) |
| "Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD." | 3.96 | Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020) |
| "In healthy term newborns with chorioamnionitis, MRS ratios shortly after birth may provide evidence of occult neuroinflammation, which may be associated with worse performance on 1-year neurodevelopmental tests." | 1.42 | Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis. ( Bentzley, JP; Brown, T; Hope, K; Jenkins, DD; Johnson, CB; Katikaneni, LD; Lambert, D; Morgan, PS; Mulvihill, DM; Ramakrishnan, V; Rollins, LG, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passi, GR | 1 |
| Pandey, S | 1 |
| Devi, ARR | 1 |
| Konanki, R | 1 |
| Jain, AR | 1 |
| Bhatnagar, S | 1 |
| Tripathi, R | 1 |
| Jain, V | 1 |
| Farmer, CA | 1 |
| Kaat, AJ | 1 |
| Thurm, A | 1 |
| Anselm, I | 1 |
| Akshoomoff, N | 1 |
| Bennett, A | 1 |
| Berry, L | 1 |
| Bruchey, A | 1 |
| Barshop, BA | 1 |
| Berry-Kravis, E | 1 |
| Bianconi, S | 1 |
| Cecil, KM | 1 |
| Davis, RJ | 1 |
| Ficicioglu, C | 1 |
| Porter, FD | 1 |
| Wainer, A | 1 |
| Goin-Kochel, RP | 1 |
| Leonczyk, C | 1 |
| Guthrie, W | 1 |
| Koeberl, D | 1 |
| Love-Nichols, J | 1 |
| Mamak, E | 1 |
| Mercimek-Andrews, S | 2 |
| Thomas, RP | 1 |
| Spiridigliozzi, GA | 1 |
| Sullivan, N | 1 |
| Sutton, VR | 1 |
| Udhnani, MD | 1 |
| Waisbren, SE | 1 |
| Miller, JS | 1 |
| Bahl, S | 1 |
| Cordeiro, D | 1 |
| MacNeil, L | 1 |
| Schulze, A | 1 |
| Hyodo, R | 1 |
| Sato, Y | 1 |
| Ito, M | 1 |
| Sugiyama, Y | 1 |
| Ogawa, C | 1 |
| Kawai, H | 1 |
| Nakane, T | 1 |
| Saito, A | 1 |
| Hirakawa, A | 1 |
| Kidokoro, H | 1 |
| Natsume, J | 1 |
| Hayakawa, M | 1 |
| Barta, H | 1 |
| Jermendy, A | 1 |
| Kolossvary, M | 1 |
| Kozak, LR | 1 |
| Lakatos, A | 1 |
| Meder, U | 1 |
| Szabo, M | 1 |
| Rudas, G | 1 |
| Johnson, CB | 1 |
| Jenkins, DD | 1 |
| Bentzley, JP | 1 |
| Lambert, D | 1 |
| Hope, K | 1 |
| Rollins, LG | 1 |
| Morgan, PS | 1 |
| Brown, T | 1 |
| Ramakrishnan, V | 1 |
| Mulvihill, DM | 1 |
| Katikaneni, LD | 1 |
6 other studies available for creatine and Neurodevelopmental Disorders
| Article | Year |
|---|---|
Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
Topics: Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Creatine; Female; Follow-Up Studies; Gua | 2022 |
Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders.
Topics: Autism Spectrum Disorder; Brain Diseases, Metabolic, Inborn; Child; Creatine; Humans; Mental Retarda | 2020 |
Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.
Topics: Brain Diseases, Metabolic, Inborn; Canada; Creatine; Female; Guanidinoacetate N-Methyltransferase; H | 2020 |
Magnetic resonance spectroscopy in preterm infants: association with neurodevelopmental outcomes.
Topics: Aspartic Acid; Brain; Child Development; Choline; Creatine; Female; Humans; Infant; Infant, Newborn; | 2018 |
Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants.
Topics: Aspartic Acid; Brain; Creatine; Epilepsy; Female; Hearing Loss; Hospital Mortality; Humans; Hypother | 2018 |
Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis.
Topics: Basal Ganglia; Brain; Choline; Chorioamnionitis; Creatine; Dipeptides; Female; Healthy Volunteers; H | 2015 |